192: Traders Cafe with Zak Mir: Andrew Simms, Head of Research at Arden on Ondine Biomedical

<div>Zak Mir talks to Andrew Simms, Head of Research at Arden as photodisinfection therapy group Ondine Biomedical debuts on AIM. </div>